Xiaoyan Xu

1.6k total citations
28 papers, 1.2k citations indexed

About

Xiaoyan Xu is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Xiaoyan Xu has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 10 papers in Cognitive Neuroscience and 10 papers in Psychiatry and Mental health. Recurrent topics in Xiaoyan Xu's work include Neurotransmitter Receptor Influence on Behavior (13 papers), Functional Brain Connectivity Studies (8 papers) and Schizophrenia research and treatment (8 papers). Xiaoyan Xu is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (13 papers), Functional Brain Connectivity Studies (8 papers) and Schizophrenia research and treatment (8 papers). Xiaoyan Xu collaborates with scholars based in United States, United Kingdom and China. Xiaoyan Xu's co-authors include Mark Slifstein, Anissa Abi‐Dargham, Lawrence S. Kegeles, Nina Urban, Judy L. Thompson, Marc Laruelle, Ragy R. Girgis, Roberto Gil, Elizabeth Hackett and John H. Krystal and has published in prestigious journals such as Biological Psychiatry, Neuropsychopharmacology and Molecular Psychiatry.

In The Last Decade

Xiaoyan Xu

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoyan Xu United States	19	642	426	331	210	208	28	1.2k
Jenny Ceccarini Belgium	24	569 0.9×	406 1.0×	220 0.7×	148 0.7×	185 0.9×	55	1.4k
Markus Savli Austria	20	380 0.6×	447 1.0×	168 0.5×	151 0.7×	139 0.7×	44	1.2k
Steven Haugbøl Denmark	15	492 0.8×	287 0.7×	172 0.5×	156 0.7×	173 0.8×	23	1.1k
Kelly A. Allers Germany	21	663 1.0×	332 0.8×	343 1.0×	285 1.4×	120 0.6×	40	1.5k
Yoshitaka Kumakura Japan	20	565 0.9×	546 1.3×	325 1.0×	160 0.8×	124 0.6×	41	1.4k
Amira K. Brown United States	14	489 0.8×	320 0.8×	175 0.5×	229 1.1×	163 0.8×	20	1.1k
Bianca Jupp Australia	25	876 1.4×	609 1.4×	300 0.9×	332 1.6×	165 0.8×	49	1.6k
Laurent Brichard United Kingdom	8	799 1.2×	547 1.3×	285 0.9×	258 1.2×	190 0.9×	11	1.3k
Karmen K. Yoder United States	27	603 0.9×	479 1.1×	310 0.9×	288 1.4×	63 0.3×	72	1.6k
Maria Rogdaki United Kingdom	19	465 0.7×	599 1.4×	672 2.0×	436 2.1×	173 0.8×	51	1.7k

Countries citing papers authored by Xiaoyan Xu

Since Specialization

Citations

This map shows the geographic impact of Xiaoyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Xu more than expected).

Fields of papers citing papers by Xiaoyan Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Xu. The network helps show where Xiaoyan Xu may publish in the future.

Co-authorship network of co-authors of Xiaoyan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Xu. A scholar is included among the top collaborators of Xiaoyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Xu. Xiaoyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosell, Daniel R., Mark Slifstein, Judy L. Thompson, et al.. (2023). Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetine. Psychopharmacology. 240(2). 361–371. 4 indexed citations

Thompson, Judy L., Daniel R. Rosell, Mark Slifstein, et al.. (2020). Amphetamine-induced striatal dopamine release in schizotypal personality disorder. Psychopharmacology. 237(9). 2649–2659. 7 indexed citations

Girgis, Ragy R., Seth C. Baker, Xiangling Mao, et al.. (2019). Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study. Psychiatry Research. 275. 78–85. 20 indexed citations

Kegeles, Lawrence S., Guillermo Horga, Rassil Ghazzaoui, et al.. (2018). Enhanced Striatal Dopamine Release to Expectation of Alcohol: A Potential Risk Factor for Alcohol Use Disorder. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 3(7). 591–598. 21 indexed citations

Girgis, Ragy R., Xiaoyan Xu, Roberto Gil, et al.. (2015). Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [11C]-(+)-PHNO. Schizophrenia Research. 168(1-2). 373–376. 20 indexed citations

Giessen, Elsmarieke van de, Daniel R. Rosell, Judy L. Thompson, et al.. (2014). Serotonin transporter availability in impulsive aggressive personality disordered patients: A PET study with [11C]DASB. Journal of Psychiatric Research. 58. 147–154. 21 indexed citations

Thompson, Judy L., Daniel R. Rosell, Mark Slifstein, et al.. (2014). Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [11C]NNC112. Psychopharmacology. 231(21). 4231–4240. 25 indexed citations

Thompson, Judy L., Nina Urban, Mark Slifstein, et al.. (2012). Striatal dopamine release in schizophrenia comorbid with substance dependence. Molecular Psychiatry. 18(8). 909–915. 85 indexed citations

Urban, Nina, Mark Slifstein, Judy L. Thompson, et al.. (2012). Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography Study. Biological Psychiatry. 71(8). 677–683. 90 indexed citations

10.

Simpson, H. Blair, Dikoma C. Shungu, James F. Bender, et al.. (2012). Investigation of Cortical Glutamate–Glutamine and γ-Aminobutyric Acid in Obsessive–Compulsive Disorder by Proton Magnetic Resonance Spectroscopy. Neuropsychopharmacology. 37(12). 2684–2692. 77 indexed citations

11.

Simpson, H. Blair, Mark Slifstein, James F. Bender, et al.. (2011). Serotonin 2A Receptors in Obsessive-Compulsive Disorder: A Positron Emission Tomography Study with [11C]MDL 100907. Biological Psychiatry. 70(9). 897–904. 32 indexed citations

12.

Urban, Nina, Mark Slifstein, Shashwath A. Meda, et al.. (2011). Imaging human reward processing with positron emission tomography and functional magnetic resonance imaging. Psychopharmacology. 221(1). 67–77. 39 indexed citations

13.

Miyake, Nobumi, Mette Skinbjerg, Dileep Kumar, et al.. (2011). Imaging Changes in Glutamate Transmission In Vivo with the Metabotropic Glutamate Receptor 5 Tracer [11C] ABP688 and N-Acetylcysteine Challenge. Biological Psychiatry. 69(9). 822–824. 51 indexed citations

14.

Girgis, Ragy R., Mark Slifstein, Xiaoyan Xu, et al.. (2011). The 5-HT 2A receptor and serotonin transporter in Asperger's Disorder: A PET study with [ 11 C]MDL 100907 and [ 11 C]DASB. Psychiatry Research Neuroimaging. 194(3). 230–234. 33 indexed citations

15.

Bullich, Santiago, Mark Slifstein, Jan Passchier, et al.. (2010). Biodistribution and Radiation Dosimetry of the Glycine Transporter-1 Ligand 11C-GSK931145 Determined from Primate and Human Whole-Body PET. Molecular Imaging and Biology. 13(4). 776–784. 9 indexed citations

16.

Kegeles, Lawrence S., Mark Slifstein, Xiaoyan Xu, et al.. (2010). Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography. Biological Psychiatry. 68(7). 634–641. 62 indexed citations

17.

Urban, Nina, Lawrence S. Kegeles, Mark Slifstein, et al.. (2010). Sex Differences in Striatal Dopamine Release in Young Adults After Oral Alcohol Challenge: A Positron Emission Tomography Imaging Study With [11C]Raclopride. Biological Psychiatry. 68(8). 689–696. 157 indexed citations

18.

Rosell, Daniel R., Judy L. Thompson, Mark Slifstein, et al.. (2010). Increased Serotonin 2A Receptor Availability in the Orbitofrontal Cortex of Physically Aggressive Personality Disordered Patients. Biological Psychiatry. 67(12). 1154–1162. 69 indexed citations

19.

Slifstein, Mark, Lawrence S. Kegeles, Xiaoyan Xu, et al.. (2009). Striatal and extrastriatal dopamine release measured with PET and [¹⁸F] fallypride. Synapse. 64(5). 350–362. 97 indexed citations

20.

Kegeles, Lawrence S., Mark Slifstein, W. Gordon Frankle, et al.. (2008). Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride. Neuropsychopharmacology. 33(13). 3111–3125. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact